Quotient Sciences

Bioanalytical Services

Bioanalytical Services

Delivering rapid bioanalytical data in discovery – pre-clinical – clinical. Bioanalysis is a critical step in the drug development process. At Quotient Sciences, we are experts in the development, validation, and application of bioanalytical assays. Our dedicated team of bioanalytical chemists are globally recognized and possess over 40 years of experience in supporting all stages of drug development, from early pre-clinical through to first-in-human (FIH), Phase I, and onwards to Phase II–III studies.

Bioanalytical expertise

• Bioanalytical assay development, validation, and application
• Liquid chromatography with tandem mass spectrometry (LC-MS/MS)
• Inductively coupled plasma tandem mass spectrometry (ICP-MS/MS)
• Gas chromatography with tandem mass spectrometry (GC-MS/MS)
• High-resolution mass spectrometry
• Liquid chromatography with ion-trap mass spectrometry (LC-TRAP-MS)
• Liquid chromatography with time-of-flight mass spectrometry (LC-TOF-MS)
• Rapid turnaround time of pre-clinical and clinical samples
• Even quicker with ‘Priority Analysis’ (72-hour turnaround time)
• Good Laboratory Practice (GLP)- and Good Clinical Practice (GCP)-accredited laboratories
• Global compliance
• US Food and Drug Administration (FDA)
• European Medicines Agency (EMA)
• UK Medicines and Healthcare products Regulatory Agency (MHRA)
• Expertise in specialist areas
• Insulin analogues and polypeptide drugs by LC-MS/MS
• Elemental analysis by inductively coupled plasma mass spectrometry (ICP-MS)
• Volatile drugs and biomarkers by gas chromatography with mass spectrometry (GC-MS)
• Metabolite identification